BGMS insider buying and SEC filings, explained
Cyclacel Pharmaceuticals, Inc. · CIK 1130166
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$1.1M
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Nov 5, 2025 | Sale | Kim Choy Yap (10% owner) sold 28,540 shares at $1.70 ($49K). Holdings down 100% to 0 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 5, 2025 |
| Oct 30, 2025 | Sale | Kim Choy Yap (10% owner) sold 112,260 shares at $1.81 ($203K). Holdings down 80% to 28,500 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 3, 2025 |
| Oct 30, 2025 | Sale | Khai Loon Kua (10% owner) sold 242,477 shares at $1.80 ($436K). Holdings down 100% to 0 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 3, 2025 |
| Oct 30, 2025 | Sale | Yee Lung Ong (10% owner) sold 248,814 shares at $1.80 ($448K). Holdings down 100% to 0 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 3, 2025 |
5 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow BGMS in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.